FDA Approved: TACROLIMUS — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved Ascend Laboratories' tacrolimus as a new generic to prevent organ transplant rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection
• Pancreas Transplant Rejection

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

ORIG AP for TACROLIMUS (TACROLIMUS)